ProjectPTC Vatiquinone FA – A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension…

Basic data

Acronym:
PTC Vatiquinone FA
Title:
A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension to assess the safety and efficacy of Vatiquinone for the treatment of Friedreich Ataxia
Duration:
01/03/2021 to 28/02/2023
Abstract / short description:
A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension to assess the safety and efficacy of Vatiquinone for the treatment of Friedreich Ataxia
Keywords:
Vatiquinone
Friedreich Ataxie
Ataxie
kontrollierte Studie
Phase 3 Studie
PTC

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Plainfield, New Jersey, United States
Help

will be deleted permanently. This cannot be undone.